Trial Profile
Study of Apixaban Oral Solution Bioavailability When Administered Through a Nasogastric Tube in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2016
Price :
$35
*
At a glance
- Drugs Apixaban (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism; Venous thromboembolism
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 20 Jan 2014 New trial record